ASIA PACIFIC ORTHOBIOLOGICS MARKET FORECAST 2019-2027
Asia Pacific Orthobiologics Market By End-user (hospitals, Orthopedic Clinics) By Products (demineralized Bone Matrix (dbm), Allograft, Bone Morphogenetic Protein (bmp), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Other Products) By Application (spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon And Ligament, Other Applications) By Geography.
The Asia Pacific market for the orthobiologics is anticipated to grow at a CAGR of 7.09%. The forecast period of the orthobiologics market in Asia-Pacific region is from 2019 to 2027. The Increasing acceptance of orthopedic diseases is one of the key factors which is rising the growth of the Asia Pacific Orthobiologics market.
The countries analyzed in the Asia Pacific region of the orthobiologics market are India, China, Japan, Australia, South Korea and the Rest of Asia-Pacific. China held the largest market share in the Asia Pacific market due to the increasing incidence of the orthopedic diseases in the region is boosting the growth in the Asia Pacific market
Moreover, the growing number of orthopedic procedures in the Asia Pacific market is driving the increase in the Asia Pacific Orthobiologics market.
Major players for the orthobiologics market are AAP Implantate AG, Allosource, Amedica Corporation, Baxter International Inc., Conmed Corporation, Depuy Inc. (Acquired By Johnson And Johnson), Exactech Inc., Integra Lifesciences Holding Corporation, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Smith & Nephew Plc, Stryker Corporation, and Zimmer Biomet Inc.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- HOSPITALS ARE THE LARGEST REVENUE GENERATING END-USER
- SPINAL FUSION IS THE FASTEST GROWING APPLICATION
- VISCOSUPPLEMENTATION HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- INCREASING GERIATRIC POPULATION
- INCREASE ORTHOPAEDIC RELATED DISEASES DUE TO LIFESTYLE CHOICES
- TECHNOLOGICAL ADVANCEMENT
- MARKET RESTRAINTS
- STRINGENT GOVERNMENT POLICIES
- POST-SURGERY COMPLICATIONS
- HIGH COST OF ORTHOPEDICS IMPLANTS
- MARKET OPPORTUNITIES
- INCREASED UTILIZATION OF BONE REGENERATION TECHNOLOGY
- GROWING DISPOSABLE INCOME
- EXPANSION OF COST EFFECTIVE MEDICAL PRODUCTS
- HUGE MARKET OPPORTUNITIES IN DEVELOPING COUNTRIES
- MARKET CHALLENGES
- HIGH COST OF SPINAL FUSION SURGERY
- POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
- MARKET BY END-USER
- HOSPITALS
- ORTHOPEDIC CLINICS
- MARKET BY PRODUCTS
- DEMINERALIZED BONE MATRIX (DBM)
- ALLOGRAFT
- BONE MORPHOGENETIC PROTEIN (BMP)
- VISCOSUPPLEMENTATION
- SYNTHETIC BONE SUBSTITUTES
- STEM CELL THERAPY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- SPINAL FUSION
- TRAUMA REPAIR
- RECONSTRUCTIVE SURGERY
- TENDON AND LIGAMENT
- OTHER APPLICATIONS
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYER
- BARGAINING POWER OF SUPPLIER
- INTENSITY OF COMPETITIVE RIVALRY
- PESTEL ANALYSIS
- PATENT ANALYSIS
- KEY BUYING CRITERIA
- VALUE CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- INDIA
- CHINA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- MARKET SHARE ANALYSIS
- COMPANY PROFILES
- AAP IMPLANTATE AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ALLOSOURCE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- AMEDICA CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BAXTER INTERNATIONAL INC.
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CONMED CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- DEPUY INC (ACQUIRED BY JOHNSON AND JOHNSON)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- EXACTECH INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- INTEGRA LIFESCIENCES HOLDING CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- MEDTRONIC INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- NUVASIVE INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- RTI SURGICAL
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SANOFI
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SMITH & NEPHEW PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- STRYKER CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- ZIMMER BIOMET INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- AAP IMPLANTATE AG
TABLE LIST
TABLE 1 ASIA PACIFIC ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
TABLE 2 POST-SURGERY COMPLICATION
TABLE 3 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC ORTHOPEDIC CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC DEMINERALIZED BONE MATRIX (DBM) MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC ALLOGRAFT MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC BONE MORPHOGENETIC PROTEIN (BMP) MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC VISCOSUPPLEMENTATION MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC SYNTHETIC BONE SUBSTITUTES MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC SPINAL FUSION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC TRAUMA REPAIR MARKET 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC RECONSTRUCTIVE SURGERY MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC TENDON AND LIGAMENT MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 20 ASIA-PACIFIC VETERINARY DIAGNOSTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
FIGURES LIST
FIGURE 1 ASIA PACIFIC ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 3 ASIA PACIFIC ORTHOBIOLOGICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 4 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 7 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCE MODEL
FIGURE 21 ASIA PACIFIC ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 22 ASIA PACIFIC ORTHOBIOLOGICS MARKET BY COUNTRY 2018 & 2027
FIGURE 23 GROWING AGING POPULATION RATE 2010 AND 2050
FIGURE 24 INDIA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 25 CHINA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 26 JAPAN VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 27 AUSTRALIA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 28 SOUTH KOREA VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 29 REST OF ASIA-PACIFIC VETERINARY DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
FIGURE 30 ORTHOBIOLOGICS COMPANY MARKET SHARE 2018 (% )
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- INDIA
- CHINA
- JAPAN
- AUSTRALIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY END USER
- HOSPITALS
- ORTHOPEDIC CLINICS
- MARKET BY PRODUCTS
- DEMINERALIZED BONE MATRIX (DBM)
- ALLOGRAFT
- BONE MORPHOGENETIC PROTEIN (BMP)
- VISCOSUPPLEMENTATION
- SYNTHETIC BONE SUBSTITUTES
- STEM CELL THERAPY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- SPINAL FUSION
- TRAUMA REPAIR
- RECONSTRUCTIVE SURGERY
- TENDON AND LIGAMENT
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.